Indonesia TB Strategy: Collaboration & Evidence-Based Control

Indonesia is on the cusp of a critical turning point in its decades-long battle against tuberculosis (TB). While the nation has historically borne a heavy TB burden – with over 1 million new cases and 134,000 deaths estimated in 2025 alone – a newly developed National Strategic Plan for Tuberculosis 2026–2030, forged through extensive collaboration with the WHO, World Bank, and other partners, offers a pathway towards genuine progress. This isn’t simply about updating existing strategies; it represents a fundamental shift towards a more evidence-based, people-centered approach, acknowledging the systemic gaps that have hindered effective TB control for years. The urgency is clear: TB remains a leading infectious disease killer globally, and Indonesia’s high incidence rate significantly contributes to that statistic.

Indonesia’s struggle with TB isn’t new. Factors contributing to the persistent high rates include a large population, poverty, limited access to healthcare in remote areas, and challenges in ensuring treatment adherence. Previous national programs, while well-intentioned, often lacked the robust data and collaborative framework needed to effectively target interventions. The recent epidemiological and National TB Programme Reviews, supported by the WHO, were crucial in pinpointing these weaknesses. These reviews highlighted deficiencies in case detection, treatment completion rates, and the overall integration of TB services within the broader healthcare system. The participatory approach taken in developing the new strategic plan – involving communities affected by TB – is a significant departure from past top-down strategies and is designed to address these long-standing issues.

The plan’s emphasis on “people-centered services” is particularly noteworthy. This means moving beyond simply providing medical treatment to addressing the social and economic factors that contribute to TB vulnerability. This includes tackling stigma, ensuring access to nutritional support, and providing financial assistance to help patients complete their treatment regimens. The involvement of civil society organizations and communities affected by TB is vital to ensuring these services are culturally appropriate and effectively reach those who need them most.

The Forward Look

The release of the draft final strategic plan is not the finish line, but rather the starting gun for a new phase of implementation. The next six months will be critical. Watch for the Ministry of Health to finalize and officially launch the plan, followed by the allocation of resources and the establishment of clear monitoring and evaluation frameworks. A key challenge will be ensuring that the plan’s ambitious goals are translated into concrete actions at the local level. Furthermore, sustained funding from sources like the Gates Foundation and the Global Fund will be essential. We can anticipate increased scrutiny of Indonesia’s TB control efforts from international health organizations, and a potential ripple effect – successful implementation could serve as a model for other high-burden countries in the region. Finally, the plan’s success hinges on strengthening collaboration between the public and private healthcare sectors, a historically complex relationship in Indonesia. Addressing this will be a key indicator of whether this new strategic plan can truly deliver on its promise of eliminating TB.